Chemed (NYSE:CHE) issued an update on its FY 2021
After-Hours earnings guidance on Tuesday morning. The company provided EPS guidance of 17.00-17.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $17.28.
NYSE:CHE traded up $4.07 during trading hours on Tuesday, hitting $481.07. 71,869 shares of the stock traded hands, compared to its average volume of 95,473. The firm has a 50 day moving average price of $522.73 and a 200 day moving average price of $502.00. Chemed has a fifty-two week low of $330.01 and a fifty-two week high of $560.00. The firm has a market cap of $7.67 billion, a price-to-earnings ratio of 29.17, a PEG ratio of 2.89 and a beta of 0.55.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 19th. Investors of record on Monday, March 1st will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend is Friday, February 26th. Chemed’s dividend payout ratio is presently 9.75%.
In other Chemed news, Director Donald E. Saunders sold 510 shares of the company’s stock in a transaction dated Friday, December 18th. The shares were sold at an average price of $526.45, for a total transaction of $268,489.50. Following the sale, the director now directly owns 6,226 shares of the company’s stock, valued at $3,277,677.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Friday, January 8th. The stock was sold at an average price of $549.30, for a total transaction of $1,098,600.00. Following the sale, the chief executive officer now directly owns 140,963 shares in the company, valued at $77,430,975.90. The disclosure for this sale can be found here. Insiders sold 5,010 shares of company stock valued at $2,680,840 in the last three months. Company insiders own 3.96% of the company’s stock.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations.
Featured Article: What is meant by a buy rating?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.